Пресса | HIPRA

who we are

Пресса

03/16/2022 - 08:45

GoodGut and Vall d'Hebron Barcelona Hospital are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

Медицина

Узнать подробнее

03/11/2022 - 10:00

AEMPS authorizes Phase IIb second clinical trial of the HIPRA’s vaccine against Covid-19

Медицина

Узнать подробнее

02/01/2022 - 15:33

AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19

Медицина

Узнать подробнее

01/20/2022 - 15:55

The European RBDCOV project will study HIPRA’s Covid-19 vaccine in children, adolescents and immunocompromised patients

Медицина

Узнать подробнее

01/13/2022 - 15:50

AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine

Медицина

Узнать подробнее

12/20/2021 - 09:15

HIPRA’s Covid-19 vaccine shows an effective immunological response with no adverse effects in preclinical trials

Медицина

Узнать подробнее